Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamilton-Wessler, M.
Right arrow Articles by Bergman, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamilton-Wessler, M.
Right arrow Articles by Bergman, R. N.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 51:574-582, 2002
© 2002 by the American Diabetes Association, Inc.

Mode of Transcapillary Transport of Insulin and Insulin Analog NN304 in Dog Hindlimb

Evidence for Passive Diffusion

Marianthe Hamilton-Wessler1, Marilyn Ader1, Melvin K. Dea1, Donna Moore1, Mette Loftager2, Jan Markussen2, and Richard N. Bergman1

1 Department of Physiology and Biophysics, University of Southern California School of Medicine, Los Angeles, California
2 Novo Research Institute, Novo Nordisk A/S, Bagsvaerd, Denmark

A defect in transcapillary transport of insulin in skeletal muscle and adipose tissue has been proposed to play a role in the insulin resistance that leads to type 2 diabetes, yet the mechanism of insulin transfer across the capillary endothelium from plasma to interstitium continues to be debated. This study examined in vivo the interstitial appearance of insulin in hindlimb using the fatty acid acylated insulin analog LysB29-tetradecanoyl des-(B30) human insulin, or NN304, as a marker for insulin transport. If the insulin transport were a saturable process, then "swamping" the capillary endothelial insulin receptors with native insulin would suppress the subsequent appearance in interstitial fluid of the insulin analog NN304. This analog binds to insulin receptors with an affinity of ~50% of native insulin. Experimental conditions established a physiologic NN304 dose in the absence or presence of pharmacologic and saturating concentrations of regular human insulin. Euglycemic clamps were performed in dogs under inhalant anesthesia with deep hindlimb lymphatic sampling, representative of skeletal muscle interstitial fluid (ISF). In group 1 (n = 8), NN304 alone was infused (3.6 pmol · min-1 · kg-1) from 60 to 360 min. In group 2 (n = 6), starting at time 0, human insulin was infused at a pharmacologic dose (60 pmol · min-1 · kg-1) with the addition of NN304 infusion (3.6 pmol · min-1 · kg-1) from 60 to 360 min. In group 3 (n = 4), the human insulin infusion was increased to a saturating dose (120 pmol · min-1 · kg-1). Pharmacologic insulin infusion (group 2) established steady-state human insulin concentrations of 6,300 ± 510 pmol/l in plasma and 5,300 ± 540 pmol/l in ISF. Saturating insulin infusion (group 3) achieved steady-state human insulin concentrations of 22,000 ± 1,800 pmol/l in plasma and 19,000 ± 1,500 pmol/l in ISF. Total (bound and unbound) NN304 plasma concentrations rose from a steady state of 1,900 ± 110 (group 1) to 2,400 ± 200 pmol/l (group 2) and 3,100 ± 580 pmol/l (group 3), consistent with a competition-driven decline in NN304 clearance from plasma as the human insulin level increased (P < 0.05 by ANOVA). Steady-state interstitial NN304 concentrations also rose with increasing human insulin levels but did not achieve significance in comparison with analog alone (162 ± 15 vs. 196 ± 22 and 241 ± 53 pmol/l for group 1 versus groups 2 and 3, respectively; P = 0.20), yet the steady-state plasma:ISF ratio for NN304 remained essentially unchanged in the absence and presence of elevated human insulin levels (12.6 ± 1.2 vs. 12.4 ± 0.5 and 13.1 ± 1.5 for group 1 versus groups 2 and 3, respectively; P = 0.93). Last, NN304 rate of appearance in interstitial fluid (i.e., half-time to steady state) was similar between groups; mean half-time of 92 ± 4 min (NS between groups). In conclusion, appearance of the insulin analog NN304 in skeletal muscle interstitial fluid was constant whether in the absence or presence of human insulin concentrations sufficient to saturate the endothelial insulin receptors. These findings support the hypothesis, provided that the mechanism of insulin and NN304 transcapillary transport is similar, that transcapillary transport of insulin in skeletal muscle occurs primarily via a nonsaturable process such as passive diffusion via a paracellular or transcellular route.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
H. Wang, A. X. Wang, Z. Liu, and E. J. Barrett
Insulin Signaling Stimulates Insulin Transport by Bovine Aortic Endothelial Cells
Diabetes, March 1, 2008; 57(3): 540 - 547.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. C. Inyard, L. H. Clerk, M. A. Vincent, and E. J. Barrett
Contraction Stimulates Nitric Oxide Independent Microvascular Recruitment and Increases Muscle Insulin Uptake
Diabetes, September 1, 2007; 56(9): 2194 - 2200.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Weinhandl, C. Pachler, J. K. Mader, D. Ikeoka, A. Mautner, A. Falk, M. Suppan, T. R. Pieber, and M. Ellmerer
Physiological Hyperinsulinemia Has No Detectable Effect on Access of Macromolecules to Insulin-Sensitive Tissues in Healthy Humans
Diabetes, September 1, 2007; 56(9): 2213 - 2217.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. Wang, Z. Liu, G. Li, and E. J. Barrett
The vascular endothelial cell mediates insulin transport into skeletal muscle
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E323 - E332.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Ellmerer, M. Hamilton-Wessler, S. P. Kim, K. Huecking, E. Kirkman, J. Chiu, J. Richey, and R. N. Bergman
Reduced Access to Insulin-Sensitive Tissues in Dogs With Obesity Secondary to Increased Fat Intake
Diabetes, June 1, 2006; 55(6): 1769 - 1775.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Ellmerer, S. P. Kim, M. Hamilton-Wessler, K. Hucking, E. Kirkman, and R. N. Bergman
Physiological Hyperinsulinemia in Dogs Augments Access of Macromolecules to Insulin-Sensitive Tissues
Diabetes, November 1, 2004; 53(11): 2741 - 2747.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Gudbjornsdottir, M. Sjostrand, L. Strindberg, J. Wahren, and P. Lonnroth
Direct Measurements of the Permeability Surface Area for Insulin and Glucose in Human Skeletal Muscle
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4559 - 4564.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Ellmerer, M. Hamilton-Wessler, S. P. Kim, M. K. Dea, E. Kirkman, A. Perianayagam, J. Markussen, and R. N. Bergman
Mechanism of Action in Dogs of Slow-Acting Insulin Analog O346
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2256 - 2262.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Sjostrand, S. Gudbjornsdottir, A. Holmang, L. Lonn, L. Strindberg, and P. Lonnroth
Delayed Transcapillary Transport of Insulin to Muscle Interstitial Fluid in Obese Subjects
Diabetes, September 1, 2002; 51(9): 2742 - 2748.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.